Literature DB >> 31773038

Hydrogel Spacer Reduces Rectal Dose during Proton Therapy for Prostate Cancer: A Dosimetric Analysis.

Praveen Polamraju1, Alexander F Bagley2, Tyler Williamson2, X Ronald Zhu3, Steven J Frank2.   

Abstract

PURPOSE: Proton therapy for prostate cancer may reduce bowel dose and risk of bowel symptoms relative to photon-based methods. Here, we determined the effect of using a biodegradable, injectable hydrogel spacer on rectal dose on plans for treating prostate cancer with intensity-modulated proton therapy (IMPT) or passive scattering proton therapy (PSPT).
MATERIALS AND METHODS: Pairs of IMPT and PSPT plans for 9 patients were created from fused computed tomography/magnetic resonance imaging scans obtained before and after spacer injection. Calculated values of rectal V40, V60, V70, V80, and maximum dose (Dmax) were compared with Wilcoxon signed rank tests. Displacements at the base (BP), midgland (MP), and apex (AP) of the prostate relative to the anterior rectal wall with the spacer in place were averaged for each patient and correlated with V70 by using linear regression models.
RESULTS: The presence of a spacer reduced all dosimetric parameters for both PSPT and IMPT, with the greatest difference in V70, which was 81.1% lower for PSPT-with-spacer than for IMPT-without-spacer. Median displacements at BP, MP, and AP were 12 mm (range 7-19), 2 mm (range 0-4), and 1 mm (range 0-5) without the spacer and 19 mm (range 12-23), 10 mm (range 8-16), and 7 mm (range 2-12) with the spacer. Modest linear trends were noted between rectal V70 and displacement for IMPT-with-spacer and PSPT-with-spacer. When displacement was ≥8 mm, V70 was ≤5.1% for IMPT-with-spacer and PSPT-with-spacer.
CONCLUSION: Use of biodegradable hydrogel spacers for prostate cancer treatment provides a significant reduction of radiation dose to the rectum with proton therapy. Significant reductions in rectal dose occurred in both PSPT and IMPT plans, with the greatest reduction for IMPT-with-spacer relative to PSPT alone. Prospective studies are ongoing to assess the clinical impact of reducing rectal dose with hydrogel spacers. © Copyright 2019 The Author(s).

Entities:  

Keywords:  IMPT; PSPT; hydrogel; prostate cancer; proton therapy

Year:  2019        PMID: 31773038      PMCID: PMC6871626          DOI: 10.14338/IJPT-18-00041.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  28 in total

1.  Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall.

Authors:  Benjamin W Fischer-Valuck; Anupama Chundury; Hiram Gay; Walter Bosch; Jeff Michalski
Journal:  Pract Radiat Oncol       Date:  2016-10-17

2.  Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.

Authors:  Carlos Vargas; Amber Fryer; Chaitali Mahajan; Daniel Indelicato; David Horne; Angela Chellini; Craig McKenzie; Paula Lawlor; Randal Henderson; Zuofeng Li; Liyong Lin; Kenneth Olivier; Sameer Keole
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-27       Impact factor: 7.038

3.  Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.

Authors:  Neil Mariados; John Sylvester; Dhiren Shah; Lawrence Karsh; Richard Hudes; David Beyer; Steven Kurtzman; Jeffrey Bogart; R Alex Hsi; Michael Kos; Rodney Ellis; Mark Logsdon; Shawn Zimberg; Kevin Forsythe; Hong Zhang; Edward Soffen; Patrick Francke; Constantine Mantz; Peter Rossi; Theodore DeWeese; Daniel A Hamstra; Walter Bosch; Hiram Gay; Jeff Michalski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-23       Impact factor: 7.038

4.  Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume?

Authors:  Larry Kestin; Neal Goldstein; Frank Vicini; Di Yan; Howard Korman; Alvaro Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-01       Impact factor: 7.038

5.  Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

Authors:  Nathan C Sheets; Gregg H Goldin; Anne-Marie Meyer; Yang Wu; YunKyung Chang; Til Stürmer; Jordan A Holmes; Bryce B Reeve; Paul A Godley; William R Carpenter; Ronald C Chen
Journal:  JAMA       Date:  2012-04-18       Impact factor: 56.272

6.  Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy.

Authors:  Emile N J Th van Lin; Jón Kristinsson; Mariëlle E P Philippens; Dirk J de Jong; Lisette P van der Vight; Johannes H A M Kaanders; Jan Willem Leer; Andries G Visser
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-08       Impact factor: 7.038

7.  Effects of prostate-rectum separation on rectal dose from external beam radiotherapy.

Authors:  Robert C Susil; Todd R McNutt; Theodore L DeWeese; Danny Song
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-24       Impact factor: 7.038

8.  The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?

Authors:  Bin S Teh; John E McGary; Lei Dong; Wei-Yuan Mai; L Steve Carpenter; Hsin H Lu; J Kam Chiu; Shiao Y Woo; Walter H Grant; E Brian Butler
Journal:  Cancer J       Date:  2002 Nov-Dec       Impact factor: 3.360

9.  Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study.

Authors:  D W Nathan Kim; Christopher Straka; L Chinsoo Cho; Robert D Timmerman
Journal:  Front Oncol       Date:  2014-11-26       Impact factor: 6.244

10.  Rectal dose to prostate cancer patients treated with proton therapy with or without rectal spacer.

Authors:  Heeteak Chung; Jerimy Polf; Shahed Badiyan; Matthew Biagioli; Daniel Fernandez; Kujtim Latifi; Richard Wilder; Minesh Mehta; Michael Chuong
Journal:  J Appl Clin Med Phys       Date:  2016-11-21       Impact factor: 2.102

View more
  6 in total

1.  Dosimetric effects of quality assurance-related setup errors in passive proton therapy for prostate cancer with and without a hydrogel spacer.

Authors:  Yuta Omi; Keisuke Yasui; Akira Shimomura; Rie Muramatsu; Hiromitsu Iwata; Hiroyuki Ogino; Akari Furukawa; Naoki Hayashi
Journal:  Radiol Phys Technol       Date:  2021-07-27

2.  Preliminary analysis of prostate positional displacement using hydrogel spacer during the course of proton therapy for prostate cancer.

Authors:  Hiroki Sato; Takahiro Kato; Tomoaki Motoyanagi; Kimihiro Takemasa; Yuki Narita; Masato Kato; Takuya Matsumoto; Sho Oyama; Hisashi Yamaguchi; Hitoshi Wada; Masao Murakami
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

3.  Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons.

Authors:  Matthew Forsthoefel; Ryan Hankins; Elizabeth Ballew; Cara Frame; David DeBlois; Dalong Pang; Pranay Krishnan; Keith Unger; Keith Kowalczyk; John Lynch; Anatoly Dritschilo; Sean P Collins; Jonathan W Lischalk
Journal:  Int J Part Ther       Date:  2022-04-06

4.  Stability of daily rectal movement and effectiveness of replanning protocols for sparing rectal doses based on the daily CT images during proton treatment for prostate cancer.

Authors:  Yoshikazu Maeda; Yoshitaka Sato; Kazutaka Yamamoto; Hiroyasu Tamamura; Makoto Sasaki; Nobukazu Fuwa; Shigeyuki Takamatsu; Kyo Kume
Journal:  J Appl Clin Med Phys       Date:  2020-09-05       Impact factor: 2.102

Review 5.  Proton Therapy for Prostate Cancer: Challenges and Opportunities.

Authors:  Darren M C Poon; Stephen Wu; Leon Ho; Kin Yin Cheung; Ben Yu
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

6.  Expanding the Utilization of Rectal Spacer Hydrogel for Larger Prostate Glands (>80 cc): Feasibility and Dosimetric Outcomes.

Authors:  Marcio Fagundes; Maria Amelia Rodrigues; Steve Olszewski; Fazal Khan; Craig McKenzie; Alonso Gutierrez; Michael Chuong; Minesh Mehta
Journal:  Adv Radiat Oncol       Date:  2021-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.